Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021239 · ClinicalTrials.gov registry record · NA
Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03021239 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 40 participants.
The verdict
NCT03021239, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The main purpose of this study is to compare Echo-guided testing to the Hemodynamic-Echo Ramp Tests to determine which method of testing provides better information for adjusting pump speed and medical treatment for Left Ventricular Assist Device (LVAD) patients. Better adjustments may provide better quality of life, exercise tolerance and reduced unwanted cardiac events over a 6-month period.
Interventions
- PROCEDURE Echo Guided Testing
- PROCEDURE Hemodynamic-Echo Ramp Testing -
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03021239
The ClinicalTrials.gov registry entry for NCT03021239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Echo Guided Testing is the first listed.
NCT03021239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03021239 about?
NCT03021239 is a clinical study titled "Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life". The main purpose of this study is to compare Echo-guided testing to the Hemodynamic-Echo Ramp Tests to determine which method of testing provides better information for adjusting pump speed and medical treatment for Left Ventricular Assist Device (LVAD) patients. Better adjustments may provide bette...
What is the current status of trial NCT03021239?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-03. Estimated completion is 2019-04.
What interventions are being tested in trial NCT03021239?
The interventions under investigation include: Echo Guided Testing (PROCEDURE), Hemodynamic-Echo Ramp Testing - (PROCEDURE).
Who is sponsoring clinical trial NCT03021239?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.